Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Candor Rx vs Vita Bella

Candor Rx
Graded #60

Higher grade

vs+9.899999999999991
Vita Bella
Graded #233

Lower grade

The verdict

Candor Rx takes it — 74.8/100 to 64.9/100.

Candor Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Candor Rx (candorrx.com) is a GLP-1 telehealth service offering compounded semaglutide and tirzepatide with flat, dose-independent pricing marketed as '$95/month, any dose, forever.' Semaglutide starts as…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCandor Rx +52
96
44
Dose & formulationCandor Rx +20
72
52
Clinical oversightVita Bella +15
76
91
Labs & monitoringVita Bella +25
52
77
FulfillmentVita Bella +12
71
83
Contract termsCandor Rx +14
61
47
Candor Rx · left barVita Bella · right bar

The numbers

MetricCandor RxVita Bella
WeighScore74.8/10064.9/100
GradeCC
Scorecard rank#60#233
Semaglutide$99/mo (all doses, compounded)Not disclosed
Tirzepatide$149/mo (all doses, compounded)$159/mo (2.5 mg dose, plus a separate fee, compounded)
CoverageCoverage not published46 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Candor Rx

Graded #60 · C

Strengths

  • Flat, dose-independent pricing marketed as '$95/month, any dose, forever' — no upcharge as your dose increases
  • Low starting prices: compounded semaglutide as low as $99/mo and tirzepatide as low as $149/mo
  • Medication ships in about 48 hours and you can cancel anytime
  • Simple, transparent GLP-1 focus with pricing shown up front before signup

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • No LegitScript certification is displayed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Vita Bella

Graded #233 · C

Strengths

  • Offers both compounded semaglutide (from $109/mo) and tirzepatide (from $159/mo) at member pricing, with supplies and a B-6 add-in included
  • Genuine LegitScript-certified website (seal #4395819) and a clearly disclosed legal entity, Vita Bella Health, LLC (Nevada)
  • Broad access: care published for 46 states plus Washington, D.C., and HSA cards are accepted
  • Fully remote telehealth with video provider consults and quarterly provider check-ins included in the membership
  • Medications dispensed by US FDA-inspected compounding pharmacies; ondansetron for nausea provided at no extra charge

Where it loses points

  • Advertised $109-$159 medication prices require a separate $129/mo membership plus a one-time $99 consult, pushing true cost to ~$238-288/mo
  • Three-month minimum commitment before it renews month-to-month; no refunds on medications and all sales are final
  • Compounding pharmacy partners are not named anywhere on the site — a transparency gap
  • Compounded semaglutide and tirzepatide are not FDA-approved; only the dispensing pharmacies are described as FDA-inspected
  • Disputes are subject to binding arbitration with a class-action waiver, governed by Nevada law (Las Vegas jurisdiction)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard